FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:405-406 August 6, 1998 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Palella, F. J. PubMed Citation

To the Editor: Palella et al. (March 26 issue)¹ reported that the use of more intensive antiretroviral therapies is responsible for declines in both morbidity and mortality in patients with AIDS. We conducted a study to evaluate the impact of protease inhibitors on the rates of selected opportunistic processes and mortality and found similar results.

Our study population came from a public human immunodeficiency virus (HIV) outpatient clinic in New Orleans. All subjects and data were from the Adult Spectrum of Disease study, a prospective study funded by the Centers for Disease Control and Prevention examining the natural history of . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Bedimo, R. J. (2008). Body-Fat Abnormalities in Patients With HIV: Progress and Challenges. J Int Assoc Physicians AIDS Care (Chic Ill) 7: 292-305 [Abstract]  
• Roland, M. E., Lo, B., Braff, J., Stock, P. G. (2003). Key Clinical, Ethical, and Policy Issues in the Evaluation of the Safety and Effectiveness of Solid Organ Transplantation in HIV-Infected Patients. Arch Intern Med 163: 1773-1778 [Full Text]  
• Gilmartin, G. S., Koziel, H. (2002). Pneumocystis Carinii Pneumonia in Adult Non-HIV Disorders. J Intensive Care Med 17: 283-301 [Abstract]  
• De Ronchi, D., Faranca, I., Berardi, D., Scudellari, P., Borderi, M., Manfredi, R., Fratiglioni, L. (2002). Risk Factors for Cognitive Impairment in HIV-1-Infected Persons With Different Risk Behaviors. Arch Neurol 59: 812-818 [Abstract] [Full Text]  
• Murphy, E. L., Collier, A. C., Kalish, L. A., Assmann, S. F., Para, M. F., Flanigan, T. P., Kumar, P. N., Mintz, L., Wallach, F. R., Nemo, G. J., for the Viral Activation Transfusion Study Investi, (2001). Highly Active Antiretroviral Therapy Decreases Mortality and Morbidity in Patients with Advanced HIV Disease. ANN INTERN MED 135: 17-26 [Abstract] [Full Text]  
• Ammassari, A., Cingolani, A., Pezzotti, P., De Luca, A., Murri, R., Giancola, M. L., Larocca, L. M., Antinori, A. (2000). AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology 55: 1194-1200 [Abstract] [Full Text]  
• Mansharamani, N. G., Garland, R., Delaney, D., Koziel, H. (2000). Management and Outcome Patterns for Adult Pneumocystis carinii Pneumonia, 1985 to 1995 : Comparison of HIV-Associated Cases to Other Immunocompromised States. Chest 118: 704-711 [Abstract] [Full Text]  
• Schwarcz, S. K., Hsu, L. C., Vittinghoff, E., Katz, M. H. (2000). Impact of Protease Inhibitors and Other Antiretroviral Treatments on Acquired Immunodeficiency Syndrome Survival in San Francisco, California, 1987-1996. Am J Epidemiol 152: 178-185 [Abstract] [Full Text]